Overview

A Study of Talazoparib in Patients With Advanced Solid Tumors

Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the mass balance of talazoparib after a single dose of talazoparib.
Phase:
Phase 1
Details
Lead Sponsor:
Medivation, Inc.
Pfizer
Collaborator:
Medivation, Inc.
Treatments:
Talazoparib